VEGFA and cancer: Here, we analyzed the oncolytic effects of GLV-5b451 and the virus-associated anti-VEGF GLAF-2-antibody production in a panel of four different canine cancer cell lines (MTH52c, ZMTH3, CT1258 and STSA-1) and in a canine soft tissue sarcoma (CSTS) xenograft model.